Drug Type Small molecule drug |
Synonyms GSK 3987, GSK-3987, GSK3987 |
Target |
Action agonists |
Mechanism LXR agonists(Liver X receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC24H20N2O3 |
InChIKeyHLZMYWLMBBLASX-UHFFFAOYSA-N |
CAS Registry264206-85-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Discovery | United States | - |